ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2012

Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.

Nandita Khera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.